Insmed Other liabilities increased by 45.6% to -$497.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 77.1%, from -$2.17M to -$497.00K. Over 2 years (FY 2023 to FY 2025), Other liabilities shows an upward trend with a -32.6% CAGR.
Fluctuations reflect changes in operational accruals and deferred income, which can impact short-term cash flow availability.
The net change in miscellaneous short-term and long-term liabilities not classified as accounts payable or debt. These o...
Commonly reported in cash flow statements; varies based on specific business model accruals.
other_increase_decrease_in_other_operating_liabilities| Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$22.98M | $6.45M | -$1.42M | -$3.74M | -$468.00K | -$5.36M | -$6.14M | -$604.00K | -$620.00K | -$4.58M | -$2.17M | -$815.00K | -$1.10M | -$914.00K | -$497.00K |
| QoQ Change | — | +128.0% | -122.1% | -162.7% | +87.5% | <-999% | -14.6% | +90.2% | -2.6% | -638.4% | +52.7% | +62.4% | -34.5% | +16.6% | +45.6% |
| YoY Change | — | — | +93.8% | -158.0% | — | — | -332.1% | +83.8% | -32.5% | +14.6% | +64.7% | -34.9% | -76.8% | +80.0% | +77.1% |